Healthcare -
Biotechnology - NASDAQ - US
$ 9.24
-2.74 %
$ 460 M
Market Cap
-2.79
P/E
MLYS - CASH & EQUIVALENTS
Cash & Equivalents MLYS - Mineralys Therapeutics, Inc.
49.3 M
LAST VALUE
115.55%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR